CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-20 | WEAVER GREGORY L Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +399,266 | 399,266 | ||
| 2017-12-20 | WEAVER GREGORY L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +399,266 | 399,266 | ||
| 2017-12-19 | Opko Health, Inc. 10% owner | Grant or award | +495,126 | 1,289,818 | ||
| 2017-12-19 | RECTOR DAVID See Remarks | Grant or award · Common Stock Option (Right to Buy) | +27,500 | 27,500 | ||
| 2017-12-19 | BRACA JOHN N See Remarks | Grant or award · Company Stock Option | +18,190 | 18,190 | ||
| 2017-12-19 | FROST PHILLIP MD ET AL See Remarks | Grant or award · Company Stock Option | +3,621 | 3,621 | ||
| 2017-12-19 | Rubin Steven D Director | Grant or award · Common Stock Option (Right to Buy) | +43,189 | 43,189 | ||
| 2017-09-19 | Opko Health, Inc. 10% owner | Conversion | +1,250,006 | 15,893,844 | ||
| 2017-09-19 | Opko Health, Inc. 10% owner | Conversion · 0% Series C Convertible Perferred | −66,667 | 0 | ||
| 2017-08-10 | Opko Health, Inc. 10% owner | Conversion | +1,563,123 | $0.10 | $156K | 12,080,139 |
| 2017-08-10 | Opko Health, Inc. 10% owner | Conversion | +2,563,699 | $0.10 | $256K | 14,643,838 |
| 2017-08-10 | Opko Health, Inc. 10% owner | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2017-08-10 | Opko Health, Inc. 10% owner | Conversion · Convertible Promissory Note | −0 | 0 | ||
| 2017-02-14 | Rubin Steven D Director | Grant or award · Company Stock Option | +160,227 | $0.11 | $18K | 160,227 |
| 2017-02-14 | FROST PHILLIP MD ET AL Director | Grant or award · Company Stock Option | +109,091 | $0.11 | $12K | 109,091 |
| 2017-02-14 | BRACA JOHN N Director | Grant or award · Company Stock Option | +167,045 | $0.11 | $18K | 167,045 |
| 2016-06-13 | Rubin Steven D Director | Grant or award · Company Stock Option | +89,773 | $0.11 | $10K | 89,773 |
| 2016-06-13 | FROST PHILLIP MD ET AL Director | Grant or award · Company Stock Option | +78,409 | $0.11 | $9K | 78,409 |
| 2016-06-13 | BRACA JOHN N Director | Grant or award · Company Stock Option | +89,773 | $0.11 | $10K | 89,773 |
| 2015-11-19 | Rubin Steven D Director | Grant or award · Company Stock Option | +40,000 | $0.25 | $10K | 40,000 |
Page 17 of 20 · 388 trades